Search

Search Results
Results 16361 - 16370 of 18734 for Depression
  • Emend IV
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Emend IV intended for persons living in Australia.
  • Largactil
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Largactil intended for persons living in Australia.
  • Catapres 150 Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Catapres 150 Tablets intended for persons living in Australia.
  • Catapres Ampoules
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Catapres Ampoules intended for persons living in Australia.
  • Catapres 100 Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Catapres 100 Tablets intended for persons living in Australia.
  • Maxolon Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Maxolon Tablets intended for persons living in Australia.
  • Otezla (apremilast)
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Otezla (apremilast) intended for persons living in Australia.
  • Dicarz
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Dicarz intended for persons living in Australia.
  • The association between handgrip strength and functional outcomes in long COVID-19
    News - 26 Jan 2024
    The association between dynapenia with long coronavirus disease 2019 (COVID-19).
  • 988-hotline counselors air concerns: More training needed to juggle a mix of calls
    News - 24 Jan 2024
    In the year and a half since its launch, 988 — the country's easy-to-remember, three-digit suicide and crisis hotline — has received about 8.1 million calls, texts, and chats.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback